Morbidity of Solid Cancer in Behçet’s Disease: Analysis of 11 Cases in a Series of 506 Patients

다국어 초록 (Multilingual Abstract)

Purpose: Behçet’s disease (BD) is rarely reported to be associated with malignancies in the literature. However, the frequency of cancer in BD patients remains unknown.
This study evaluated cancer morbidity in BD patients compared with that in the general population of Korea. Materials and Methods: A retrospective chart review was performed on 506 patients visiting our hospital from 1994 to 2011 for BD. We analyzed the standardized morbidity rate (SMR), which is the ratio of observed to expected malignancies. Furthermore, we reviewed cases of solid cancer in BD patients in the literature. Results: Of the 506 patients with BD, 11 (2.17%) developed cancer. We found a variety of solid cancers without predominance and no hematologic malignancies. The total number of cancers observed was less than expected, which was determined from the statistical data of the National Cancer Information Center of Korea, with an SMR of 0.023 (95% confidence interval, 0.012-0.039). Conclusion: BD may be associated with a lower cancer-related morbidity compared with the general population of Korea.

참고문헌 (Reference)

1 권기민, "베체트병 환자에서 발생된 간내 및 복부 피하조직 전이를 동반한 간의 원발성 평활근육종 1예" 대한간학회 11 (11): 386-391, 2005

2 Tagami H, "Unusual case of malignant pharyngeal granuloma--with symptoms resembling Behcet’s syndrome" 65 : 253-261, 1970

3 Tamaoki N, "Thymic change in Behçet’s disease" 21 : 201-213, 1972

4 Kammori M, "The pathological findings of vasculitis simultaneously occurring with carcinoma, invasive breast carcinoma in a patient with Behçet’s disease" 13 : 378-381, 2006

5 Kural-Seyahi E, "The long-term mortality and morbidity of Behçet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center" 82 : 60-76, 2003

6 Muramatsu M, "The development of malignant rhabdoid tumor in a patient with Behçet’s disease treated with ciclosporin" 236 : 798-799, 1998

7 Bang D, "Ten Cases of Behcet’s disease associated with Tumor, In Behcet’s disease" Design Mecca Publishing Co 526-528, 2000

8 Akpolat T, "Small-cell carcinoma as a cause of superior vena cava syndrome in a patient with Behçet’s disease" 67 : 593-, 2000

9 Chargari C, "Severe acute radiation-related skin toxicity in a breast cancer patient with Behçet’s disease" 91 : 139-, 2009

10 Kaklamani VG, "Role of polymorphisms in Adamantiades-Behçet’s disease" 35 : 2376-2378, 2008

11 Mizushima Y, "Revised diagnostic criteria for Behçet’s disease in 1987" 28 : 66-70, 1988

12 Oishi S, "Pheochromocytoma associated with Behçet’s disease" 19 : 283-286, 1989

13 Lioté F, "Methotrexate related B lymphoproliferative disease in a patient with rheumatoid arthritis. Role of Epstein-Barr virus infection" 22 : 1174-1178, 1995

14 Satolli F, "Merkel-cell carcinoma in Behçet’s disease" 85 : 79-, 2005

15 Pankhurst T, "Malignancy is increased in ANCA-associated vasculitis" 43 : 1532-1535, 2004

16 Cengiz M, "Malignancy in Behçet’s disease: a report of 13 cases and a review of the literature" 20 : 239-244, 2001

17 Szekanecz Z, "Malignancies in autoimmune rheumatic diseases - a mini-review" 57 : 3-10, 2011

18 Liang JA, "Malignancies associated with systemic lupus erythematosus in Taiwan: a nationwide population-based cohort study" 32 : 773-778, 2012

19 Mezalek ZT, "Kaposi’s sarcoma in association with Behcet’s disease: case report and literature review" 36 : 328-331, 2007

20 Baltaci S, "Invasive bladder carcinoma in a patient with Behçet’s disease" 10 : 669-671, 2003

21 Criteria for diagnosis of Behçet’s disease, "International Study Group for Behçet’s Disease" 335 : 1078-1080, 1990

22 Zandman-Goddard G, "Infections and SLE" 38 : 473-485, 2005

23 So MW, "Idiopathic inflammatory myopathy associated with malignancy: a retrospective cohort of 151 Korean patients with dermatomyositis and polymyositis" 38 : 2432-2435, 2011

24 Kötter I, "HHV8 associated Kaposi’s sarcoma during triple immunosuppressive treatment with cyclosporin A, azathioprine, and prednisolone for ocular Behçet’s disease and complete remission of both disorders with interferon alpha" 60 : 83-86, 2001

25 Meyer J, "Formation of a bronchoesophageal fistula following concurrent radiation and chemotherapy for lung cancer in the setting of Behçet’s disease" 3 : 1361-1362, 2008

26 Chen MR, "Epstein-barr virus, the immune system, and associated diseases" 2 : 5-, 2011

27 Celik I, "Cyclophosphamide-associated carcinoma of the urinary bladder in Behçet’s disease" 81 : 239-, 1999

28 Yamada M, "Colon cancer arising in an ulcer scar due to intestinal Behçet’s disease" 50 : 429-432, 2011

29 Lee JE, "Colon Cancer in Behcet’s Disease" 23 : 124-130, 2006

30 Rubin DC, "Chronic intestinal inflammation:inflammatory bowel disease and colitis-associated colon cancer" 3 : 107-, 2012

31 Abu-Shakra M, "Cancer in systemic sclerosis" 36 : 460-464, 1993

32 Hamza MH, "Cancer complicating Behçet’s disease treated with chlorambucil" 45 : 789-, 1986

33 Kaklamani VG, "Behçet’s disease associated with malignancies. Report of two cases and review of the literature" 23 (23): S35-S41, 2005

34 Bethea L, "Behçet’s disease and pheochromocytoma" 295-298, 1999

35 Sakane T, "Behçet’s disease" 341 : 1284-1291, 1999

36 Ahn JK, "Behcet’s disease associated with malignancy in Korea: a single center experience" 30 : 831-835, 2010

37 Shahram F, "Behcet’s disease and malignancy, report of 11 cases, In Behcet’s disease" Design Mecca Publishing Co. 515-519, 2000

38 Direskeneli H, "Autoimmunity vs autoinflammation in Behcet’s disease: do we oversimplify a complex disorder?" 45 : 1461-1465, 2006

39 Harada M, "A human T-cell lymphotropic virus type-1 (HTLV-1) carrier complicated with various autoimmune diseases including primary biliary cirrhosis" 31 : 116-119, 2005

40 Kamata T, "A case report of the development of intestinal Behcet disease immediately after sigmoidectomy for sigmoid cancer" 21 : 2331-2334, 1988

41 Nishimura K, "A case of hilar bile duct cancer with intestinal Behçet’s disease" 51 : 169-173, 2004

42 Murata I, "A case of Behçet disease associated with hepatocellular carcinoma" 35 : 625-631, 1989